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GenderGrooming behavior is an adaptation to a stressful environment that can vary in accordance with stress
intensity. Direct and indirect GABAA receptor agonists decrease duration, frequency, incorrect transitions and
uninterrupted bouts of grooming. Hormonal variation during the different phases of the estrous cycle of
female rats also changes the grooming behavior. It is known that GABAA agonists and endogenous hormones
change anxiety-like behaviors observed in the elevated plus maze test, a classical animal model of anxiety.
This study was designed to determine the anxiolytic effect of clonazepam in female rats in different estrous
phases and to correlate anxiety behaviors in the elevated plus maze and grooming microstructure tests. Our
results show that female rats displayed higher anxiety-like behavior scores during the estrus and proestrus
phases in the elevated plus maze and that clonazepam (0.25 mg/kg; i.p.) had an anxiolytic effect that was
independent of the estrous phase. Grooming behaviors were higher in the proestrus phase but were
decreased by clonazepam administration, independent of the estrous phase, demonstrating the anxiolytic
effect of this drug in both animal models. Grooming behaviors were moderately associated with anxiolytic-
like behaviors in the elevated plus maze test. Here, we describe the anxiolytic effect of clonazepam and the
inﬂuence of estrous phase on anxiety. Moreover, we show that the grooming microstructure test is a useful
tool for detecting anxiolytic-like behaviors in rats.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Grooming is a behavior observed in many species, such as
chimpanzees (Falk, 1958), mice (Rohte, 1968; Yerkes, 1933) and rats
(Bolles, 1960) and is considered an adaptation to stressful situations
(Kametani, 1988). It is deﬁned as a series of voluntarymovements,with
a cephalocaudal sequence (Gispen and Isaacson, 1981; Sachs, 1988)
that can be decreased in the presence of very intense excitation (Barros
et al., 1994). Stressors like moistening, novelty-inducing or immersion
can also increase grooming in rats (Eguibar and Moyaho, 1997; van Erp
et al., 1994). Therefore, grooming behavior sequence analysis may be a
valuable tool in detecting pharmacological effects in animal models of
anxiety (Kalueff and Tuohimaa, 2004, 2005a; Kalueff et al., 2007).
Gamma amino butyric acid (GABA) agonists, like clonazepam,
decrease grooming behaviors in rats exposed to a novel environment;
GABA antagonists reverse this effect (Barros et al., 1994). Diazepam does
not alter grooming activity in mice, but it does decrease some speciﬁcevier OA license.measures, such as the rate of incorrect transitions (Bert et al., 2001;
Kalueff and Tuohimaa, 2005a; Lepicard et al., 2000). In the elevated plus
maze test (EPMT), a classical anxiety animal model, different patterns
are produced in each estrous phase in mice, with a greater amount of
time spent in the open arm in the methaestrus>proestrus>estrous>
diestrus (Galeeva and Tuohimaa, 2001).
Interestingly, males display a higher grooming duration than
females, though females engage in greater general activity when
exposed to a novel environment (Thor et al., 1988). Additionally,
grooming activity is higher in the diestrus than in the estrus phase in
female rats, suggesting a physiological inﬂuence of ovarian steroid
hormones on this behavior (Díaz-Véliz et al., 2000). Aromatase
knockout mice, characterized by deﬁcient estrogen production, show
excessive grooming behavior that is reversed by 17β-estradiol
replacement (Hill et al., 2007). Treatment with GABAA receptor
agonists such as diazepam and THIP (4,5,6,7-tetrahydroisoxazolo[5,4-c]
pyridin-3-ol) decrease the duration of grooming in all phases of the
estrous cycle (Díaz-Véliz et al., 2000). They also cause a generalized
inhibition of grooming in both castrated male and female rats (Paredes
et al., 1997). Studies show that steroid hormones increase the number
of GABAA receptors (Maggi and Perez, 1984, 1986) and GABA synthesis
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benzodiazepines in rodents. Moreover, the estrus and the diestrus
phases appear to be more sensitive to the anxiolytic effect of these
drugs (Bitran and Dowd 1996; Carey et al., 1992).
Most of the published grooming results are obtained by the evalua-
tion of this behavior as a component of the ethological proﬁle of some
animal models. This is in contrast to the grooming microstructure
analysis proposed by Kalueff and Tuohimaa (2005a), which appears to
be more sensitive. Therefore, this new type of grooming analysis along
with classical animal models, such as the elevated plusmaze, may be an
important means of determining anxiety-like behaviors in animals. Our
present study was designed to determine the anxiolytic effect of
clonazepam in each estrous phase in female rats and to correlate the
behaviors observed in the elevated plusmaze test and groomingmicro-
structure test.
2. Methods and materials
2.1. Animals
Female Wistar rats (200–260 g; n=77) were obtained from the
Animal House of Universidade Federal de Ciências da Saúde de Porto
Alegre. Animals were housed in groups of ﬁve per polypropylene
cage with wood shavings as bedding. Food andwater were available ad
libitum, and the animals were maintained in a temperature-controlled
room (22±2 °C) under a light–dark cycle (7:00 a.m.–7:00 p.m.).
Animals were randomly chosen to receive either clonazepam (CNZ)
(0.25 mg/kg; i.p.) or vehicle (CTR) after characterization of the speciﬁc
estrous phase (Methaestrus, Estrus, Proestrus or Diestrus). Vaginal
smear analysis and ethological evaluation of behaviors were performed
between 12:00–4:00 p.m. All in vivo experiments followed the
guidelines of the International Council for Laboratory Animal Science
(ICLAS) and were approved by the Ethical Committee for Research of
UFCSPA. All efforts were made to minimize animal suffering and to
use only the number of animals necessary to produce reliable scientiﬁc
data.
2.2. Monitoring the estrous cycle
Estrous cycle were monitored by daily collection (12:00–1:00 p.m.)
of vaginal smears during ﬁve consecutive days before the behavioral
tests. Another smear was collected one hour prior to drug injection.
Vaginal smearswere prepared by addition of saline and collectedwith a
micropipette. The extracted ﬂuid was spread on glass slides and
observed under a microscope. The smear was observed ﬁrst using
10× lens, and then cellular evaluation was conﬁrmed by observation
using a 40× objective. The estrous cycle phase was determined in
accordance with Marcondes et al. (2002). Female rats were excluded
from the study when they presented an irregular cycle, when the same
phase was observed for four consecutive days, or when they did not
follow the sequence proestrus–estrus–methaestrus–diestrus–proestrus
(or indeterminate) phase. The number of animals observed in each
phase and used for subsequent analyses was as follows: methaestrus
(n=30), estrus (n=20), diestrus (n=18), and proestrus (n=9).
2.3. Treatments
Clonazepam (0.25 mg/ml, Rivotril) was dissolved in distilled
water with 0.05% Tween 80 immediately before administration
(Gomez and Barros, 2003). Animals received a single injection of
either clonazepam or vehicle solution (1 ml/kg) 35 min before the
elevated plus maze test (5 min) and were then immediately exposed
to the grooming test (15 min). This dose was selected following
previous studies from our group (Gomez and Barros, 2000). The
timeline of experiments was planned to match the plasmatic peak ofclonazepam with the behavioral observations (Hoogerkamp et al.,
1996).2.4. Elevated plus maze test
The maze test was designed according to Pellow and File (1986)
and consisted of a plus shape of two opposing enclosed arms
(50×10×40 cm) with walls of 15 cm in height, and two opposing
open arms (50×10 cm, without walls), forming a plus shape. The
apparatus had a central platform area (10×10 cm) and was elevated
50 cm above the ﬂoor. The test lasted for 5 min and began when each
rat was placed in the central area of the maze facing an open arm. The
test was recorded by a camera placed 110 cm above the ﬂoor for later
behavioral analysis. The maze was cleaned with ethanol (70%) after
each rat test. The testing roomwas illuminated by a dim light (25 W).
The behaviors observed were the duration, frequency, percentage of
time, and time per behavior on both arms. In addition, complemen-
tary behaviors, such as head-dipping (when the animal is in the open
arm with its head advanced to the edge of the platform) and closed
arm return behavior (when the rat is in the closed arm and stretches
forward to the open arm but then retracts to its original position
without any forward locomotion: classiﬁed as “protected” closed arm
return) (Cruz et al., 1994; de Paris et al., 2000; Galvis-Alonso et al.,
2010) were observed. Cross frequency was classiﬁed and quantiﬁed
as when the animal crossed the central part of the apparatus, going
from an open arm to the other or from a closed arm to the other.2.5. Grooming analysis
For grooming analyses, animals were placed inside a cylinder with
a diameter of 20 cm surrounded by 30 cm high white walls and a
transparent ﬂoor. A camera placed 10 cm below the apparatus ﬂoor
was used to record animal behavior and provide a detailed record of
activity. The test comprised two sessions 24 h apart: training
(15 min) and test (15 min). In both sessions, an individual rat was
placed in the center of the cylinder. Only the test session was
recorded. The testing room was illuminated by a dim light (25 W),
and the cylinder was cleaned with ethanol (70%) after each rat test. A
classical analysis of grooming behaviors was performed and consisted
of the number of bouts (NB) (previously called frequency of
grooming), latency to start grooming, and total time of grooming
(TTG) (Barros et al., 1994; Kalueff and Tuohimaa, 2005a). The
modiﬁed grooming microstructure analysis was measured by the
grooming actions sequence: (1) paw licking, (2) snout washing,
(3) head washing, (4) body grooming/scratching, (5) hind legs and
genital washing, and (0) no grooming (Kalueff and Tuohimaa, 2005a).
An action (NA) refers to any of the behavior numbers listed above,
except for“0”. Quantiﬁcation of the grooming action sequence was
performed using an algorithm for posterior analysis (Kalueff and
Tuohimaa, 2004, 2005a). A bout (NB) is a single action that is
interrupted, no grooming actions (0), for at least 3 s, or a sequence of
actions, until they are interrupted. A complete bout (CB) consists of
the following sequence of actions: 0–1–2–3–4–5–0 or 1–2–3–4–5.
The following parameters were also determined: the number and
percentage of complete bouts (NCB) and incomplete bouts (NIB=
NB−NCB), average duration of a bout (ADB), average duration of
an action (ADA) and average number of transitions per bout
(ANT=NA/NB). In addition, the number of correct transitions (CT)
(0–1; 1–2; 2–3; 3–4; −5; 5–0), the number of incorrect transitions
(IT), any other transitions, the total number of transitions (NT) and
the percentage of correct transitions (%CT=CT/NT) and incorrect
transitions (%IT=IT/NT) were also analyzed (Kalueff and Tuohimaa,
2005a). Defecation was scored as an additional parameter to detect
stress and anxiety stimuli.
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All the behavioral analyses were video recorded and then
analyzed by the same observer, who was blind to the animal group
allocation. The behaviors of interest were quantiﬁed using basic
software (Kevin Willioma, KD Ware Computer, Boston, MA).
2.7. Statistical analysis
A two-way ANOVA, followed by a Tukey test when appropriate,
was used to determine if there were any estrous cycle phase-
dependent effects of clonazepam on the behavior of female rats.
Pearson's correlation was used to determine if there was any
association between behaviors in the elevated plus maze and the
grooming tests. All data are presented as the means±standard error
of the mean. When the data failed the normality test and/or equal
variance test, it was normalized with logarithm transformation. This
transformation was made to the number of complete and incomplete
bouts. Differences were considered signiﬁcant at Pb0.05.
3. Results
3.1. The effects of clonazepam on the behavior of female rats in different
estrous phases during an elevated plus maze test
Clonazepam had an anxiolytic effect on female rats that was
conﬁrmed by different parameters in the elevated plus maze
test. Clonazepam-treated animals spent more time in the open arms
[F(1,73)treatment=8.673, P=0.005; Fig. 1A], displayed a higher crossing
frequency [F(1,73)treatment=9.504, P=0.003; Fig. 1B] and spent more
time performing head-dipping behavior [F(1,73)treatment=8.244,
P=0.006; Fig. 1C]. Clonazepam-treated rats spent more time per visitFig. 1. Effect of clonazepam (CNZ) versus control treatment on behaviors in the elevat
(E), methaestrus (M) and diestrus (D) phases. Small ﬁgures show effect of clonazepam tre
(C) head-dipping duration and (D) closed arm return duration. Each bar represents the mea
compared to control group. ⋄Pb0.05 and ⋄⋄Pb0.01, compared to methaestrus and diestr
clonazepam treated group.in the open arms than control rats [F(1,73)treatment=5.934, P=0.018].
Similar results were observed when the percentage of time spent in the
open arm was calculated, clonazepam-treated animals spending ~25%
of the total time in the open arm compared to only ~11% for control rats
[F(1,73)treatment=8.588, P=0.005] (data not shown). Clonazepam-
treated rats also performed fewer closed arm returns [F(1,73)treatment=
13.394, Pb0.001] and displayed a higher head-dipping frequency
[F(1,73)treatment=9.946, P=0.003] (data not shown). However, there
was no overall effect of the different estrous cycle phases for all behaviors
in the EPMT: open arms duration [F(3,73)phase=0.750, P=0.527];
crossing frequency [F(3,73)phase=1.735, P=0.169]; head-dipping
duration [F(3,73)phase=0.940, P=0.428]; duration per open arms
visit [F(3,73)phase=0.672, P=0.573]; percentage of time in the open
arms [F(3,73)phase=0.759, P=0.522]; closed arm returns [F(3,73)phase=
0.586, P=0.626]; head-dipping frequency [F(3,73)phase=0.971,
P=0.413]; closed arm return duration [F(3,73)phase=2.484, P=0.070] .
There was an important interaction observed in the closed arm return
duration [F(3,73)treat×phase=4.235, P=0.009; Fig. 1D] between the
clonazepam treatment and estrous phases. Control female rats in
the estrus and proestrus phase showed higher levels of closed arm
return behavior than rats in the methaestrus (P=0.003, P=0.011,
respectively) and diestrus phases (P=0.010, P=0.034, respectively).
Clonazepam treatment led to a reduction in the high scores observed in
the estrus (Pb0.001) and proestrus (Pb0.001). There were no in-
teractions between treatment and estrous phases in the others elevated
plus maze parameters: open arms duration [F(3,73)treat×phase=0.270,
P=0.847]; crossing frequency [F(3,73)treat×phase=0.068, P=0.977];
head-dipping duration [F(3,73)treat×phase=0.187, P=0.905]; duration
per open arms visit [F(3,73)treat×phase=0.047, P=0.986]; percentage
of time in the open arms [F(3,73)phase=0.279, P=0.840]; closed arm
returns [F(3,73)treat×phase=0.409, P=0.747]; head-dipping frequency
[F(3,73)treat×phase=0.621, P=0.604].ed plus maze test in female rats in different estrous phases: proestrus (P), estrus
atment independent of estrous phase. (A) Open arm duration, (B) crossing frequency,
n±S.E.M. Comparisons were made using a two-way ANOVA and Tukey test. **Pb0.01,
us in the control group. #Pb0.05 and ##Pb0.01, compared to the same phase in the
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estrous cycle phases during grooming tests
Classical grooming measurements were also altered by clonazepam
administration. Clonazepam increased the latency to start grooming
[F(1,73)treatment=5.002, P=0.029] (data not shown), decreased the
total time of grooming [F(1,73)treatment=43.137, Pb0.001; Fig. 2A] and
the number of bouts [F(1,73)treatment=25.362, Pb0.001; Fig. 2B], but
did not alter defecation [F(1,73)treatment=1.975, P=0.165] (data not
shown). As expected, the grooming microstructure analysis detected
signiﬁcant alterations in almost all parameters. When the correct
sequence was analyzed, there were important differences observed
between treated and control animals. Clonazepam treatment decreased
the number of total transitions [F(1,73)treatment=60.904, Pb0.001;
Fig. 2C], leading to a decrease of the number of incorrect transitions
[F(1,73)treatment=52.356, Pb0.001] (data not shown) and correct
transitions [F(1,73)treatment=33.487, Pb0.001] (data not shown), how-
ever the percentage of correct transitions increased [F(1,73)treatment=
7.382, P=0.008; Fig. 2D]. The alterations in grooming patterns resulted
in a decrease in the number of complete [F(1,73)treatment=8.257,Fig. 2. Effect of clonazepam (CNZ) versus control treatment on behaviors in the classical and
(P), estrus (E), methaestrus (M) and diestrus (D) phase. Small ﬁgures show effect of clon
grooming and (B) number of bouts. Microstructure analysis: (C) total transitions, (D) % of co
Each bar represents the mean±S.E.M. Comparisons were made using a two-way ANOVA a
⋄Pb0.05, compared to diestrus in the control group. #Pb0.05, compared to the same phasP=0.006] (data not shown) and incomplete bouts [F(1,73)treatment=
13.867, Pb0.001] (data not shown), however, therewas no alteration in
the percentage of complete [F(1,73)treatment=0.065, P=0.800] (data
not shown) or incomplete bouts [F(1,73)treatment=0.083, P=0.774,
Fig. 2E]. Animals treatedwith clonazepam presented a lower number of
actions [F(1,73)treatment=86.734, Pb0.001], but the duration of each
action [F(1,73)treatment=0.351, P=0.556] and the number of actions
per bout [F(1,73)treatment=2.506, P=0.119] were not altered (data
not shown). We did not observe any overall effect of different estrous
cycle phases for all behaviors in the grooming test: latency to start
grooming [F(3,73)phase=1.548, P=0.212]; total time of grooming
[F(3,73)phase=0.147, P=0.931]; number of bouts [F(3,73)phase=
1.068, P=0.369]; number of total transitions [F(3,73)phase=1.454,
P=0.237]; number of incorrect transitions [F(3,73)phase=0.368,
P=0.776]; correct transitions [F(3,73)phase=0.095, P=0.963];
percentage of correct transitions [F(3,73)phase=2.206, P=0.096];
number of complete bouts [F(3,73)phase=0.068, P=0.977]; num-
ber of incomplete bouts [F(3,73)phase=1.346, Pb0.268]; percentage
of complete bouts [F(3,73)phase=2.275, P=0.059]; percentage
of incomplete bouts [F(3,73)phase=0.105, P=0.764]; number ofin the grooming microstructure test in female rats in different estrous phases: proestrus
azepam treatment independent of estrous phase. Classical analysis: (A) total time of
rrect transitions, (E) % number of incomplete bouts, and (F) average duration of a bout.
nd Tukey test when necessary. **Pb0.01 and ***Pb0.001, compared to control group.
e in the clonazepam treated group.
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[F(3,73)phase=1.191, P=0.321] and the number of actions per
bout [F(3,73)phase=1.830, P=0.152]. The only interaction observed
between grooming parameters and the estrous cycle was the average
duration of a bout [F(3,73)treat×phase=4.238, P=0.009; Fig. 2F], with
females in the control proestrus phase presenting higher scores
than females in the control diestrus phase (P=0.013). Also, in the
clonazepam treated group this high value of the average duration of a
bout in the proestruswas strongly lower compared to control (Pb0.001),
leading to levels similar to the other phases. There were no inter-
actions between treatment and estrous phases in the others grooming
test parameters: latency to start grooming [F(3,73)treat×phase=2.094,
P=0.064]; total time of grooming [F(3,73)treat×phase=0.881, P=0.456];
number of bouts [F(3,73)treat×phase=0.945, P=0.424]; number of
total transitions [F(3,73)treat×phase=2.038, P=0.119]; number of
incorrect transitions [F(3,73)treat× phase=0.288, P=0.834]; correct
transitions [F(3,73)treat ×phase=0.484, P=0.695]; percentage of
correct transitions [F(3,73)treat ×phase=0.849, P=0.449]; number
of complete bouts [F(3,73)treat× phase=0.802, P=0.497]; number of
incomplete bouts [F(3,73)treat ×phase=0.434, Pb0.730]; percentage
of complete bouts [F(3,73)treat×phase=0.888, P=0.453]; percentage
of incomplete bouts [F(3,73)treat×phase=0.133, P=0.712]; lower
number of actions [F(3,73)treat×phase=1,932, P=0.134]; duration of
each action [F(3,73)treat×phase=2.212, P=0.096] and the number of
actions per bout [F(3,73)treat×phase=1.305, P=0.282].3.3. Correlation between elevated plus maze and grooming tests
Correlation analyses were performed to compare data obtained in
the elevated plus maze test and in the grooming test. There were a total
of sixty-eight medium- and weak-signiﬁcant correlations between the
seventeen elevated plusmaze test behaviors and the fourteen grooming
behaviors studied in this experiment (Table 1). The statistically
signiﬁcant correlation values were all between (−) 0.257 and
(−) 0.509. Most of the signiﬁcant correlations observed concerned the
number of bouts, number of actions, total time of grooming, number of
transitions, number of correct transitions, and incorrect transitions
(grooming test), and the closed arm return parameters – frequency,
duration, time per behavior and percentage – (elevated plusmaze test).
A notable observation was that the head-dipping frequency had eight
signiﬁcant correlations with grooming behaviors.Table 1
Correlation among elevated plus maze behaviors and grooming behaviors.
Def. Lat. NB TTG ADB ADA ANT
OA Freq. 0.116 0.048 −0.058 −0.069 −0.017 0.251 −020
OA Dur. 0.196 0.098 −0.259a −0.333a −0.175 0.140 −0.2
T. p/OA 0.285a 0.205 −0.267a −0.329a −0.141 −0.050 −0.0
% OA 0.199 0.100 −0.258a −0.331a −0.176 0.138 0.2
CA Freq. 0.153 0.088 −0.066 −0.044 0.074 0.202 −0.1
CA Dur. −0.113 −0.021 0.132 0.204 0.138 −0.168 0.3
T. p/CA −0.117 −0.053 0.110 0.148 0.090 −0.184 0.1
% CA 0.125 −0.015 0.067 0.025 0.000 −0.259a 0.0
Cross Freq. 0.100 0.129 −0.084 −0.177 −0.148 0.129 −0.2
CAR Freq. −0.178 −0.159 0.417a 0.359a 0.101 0.021 0.0
CAR Dur. −0.230 −0.150 0.363a 0.479a 0.206 0.042 0.0
T. p/CAR −0.098 −0.002 0.161 0.424a 0.344a 0.000 0.3
% CAR −0.228 −0.148 0.364a 0.479a 0.205 0.040 0.0
HD Freq. 0.266a 0.074 −0.263a −0.360a −0.258 0.119 −0.2
HD Dur. 0.216 −0.003 −0.283a −0.355a −0.189 0.197 −0.2
% HD −0.009 0.066 −0.230 −0.287a −0.110 0.264a −0.2
T. p/HD 0.079 −0.160 −0.198 −0.077 0.158 0.228 0.1
Pearson correlation test was used and R values are represented. Grooming: defecation (Def.)
a bout (ADB), average duration of an action (ADA), average number of transitions (ANT), num
transitions (NT), number of correct transitions (CT),number of incorrect transitions (IT) and
and head-dipping (HD), duration (Dur.), frequency (Freq.) time per (T. p/) and %, and cros4. Discussion
Our results from this study show that the benzodiazepine,
clonazepam, has an anxiolytic effect on female rats, regardless of cycle
phase. This was conﬁrmed by the greater amount of time spent in the
open arms in the elevated plus maze test. The anxiolytic effect of
clonazepam was also conﬁrmed by almost all other parameters
analyzed, such as the decrease in closed arm return and head-dipping
duration that are suggested to be behavioral evidence of an anxious
state in animals (Navarro et al., 2002; Walf and Frye, 2007).
Interestingly, control animals in the proestrus and estrus phases
displayed higher levels of closed arm return than animals in the
methaestrus and diestrus phases,while clonazepam treatment reversed
this difference. Previous studies have suggested that estrous cycle
phases evoke different durations in the open arm during the elevated
plus maze test (methaestrus>proestrus>estrus>diestrus) (Galeeva
and Tuohimaa, 2001). However other studies have shown no difference
between phases in elevated plus maze test parameters, aside from the
different estrous phase analysis methodology (Gouveia and Morato,
2002). Here, we did not see any signiﬁcant difference in the open arm
duration between phases, although the diestrus phase animals did
show a greater tendency to stay in the open arms.
Our observed results of closed arm return behavior in control
animals suggest an important role of proestrus and estrus phases on
the anxiety state measured in the EPMT, but after the treatment with
clonazepam the increased scores in these two phases were reduced to
the same levels of the other phases. This may conﬁrm the hypothesis
that endogenous hormones play an important role in anxiety-like
behaviors in female animals. Interestingly, Marcondes et al. (2001)
compared male and female rats and observed that females in the
proestrus and diestrus phases that were treated with estradiol
displayed greater open arm duration than control diestrus females.
The study also showed that the elevated plus maze test did not
produce progesterone or estradiol ﬂuctuations per se in control rats
(Marcondes et al. 2001). Moreover, female rats in the diestrus phase
treated with estradiol displayed the same behavioral pattern than
those in the proestrus phase (Marcondes et al., 2001). Nevertheless,
progesterone has a potent anxiolytic effect in many behavioral tests
in rodents, and serum and cortical allopregnanolone levels were
increased in another study (Bitran and Dowd, 1996). After one week
of progesterone treatment, mice spent less time in the open arm;
however, no changes were observed after one week of estradiolNIB NCB %NCB NT CT IT %CT
5 −0.050 −0.021 0.000 −0.183 −0.170 −0.354a 0.080
23 −0.233 −0.204 −0.058 −0.389a −0.341a −0.462a 0.194
18 −0.237 −0.239 −0.065 −0.331a −0.281a −0.345a 0.146
22 −0.232 −0.203 −0.059 −0.388a −0.341a −0.461a 0.191
69 −0.044 −0.092 −0.070 −0.141 −0.138 −0.297a −0.022
07a 0.116 0.122 −0.060 0.238 0.184 0.332a −0.192
99 0.060 0.229 0.137 0.243 0.233 0.332a −0.110
78 0.060 0.076 0.021 0.140 0.126 0.180 −0.073
38 −0.049 −0.159 −0.073 −0.257a −0.219 −0.459a 0.141
06 0.380a 0.269a 0.106 0.377a 0.350a 0.301a −0.204
82 0.328a 0.245 0.103 0.425a 0.395a 0.467a −0.249
30a 0.136 0.134 0.072 0.360a 0.325a 0.479a −0.210
83 0.329a 0.244 0.101 0.426a 0.395a 0.468a −0.252
99a −0.234 0.221 −0.050 −0.425a −0.384a −0.509a 0.169
60 −0.250 −0.252 −0.114 −0.381a −0.334a −0.433a 0.291a
66a −0.200 −0.205 −0.086 −0.374a −0.321a −0.437a 0.189
27 −0.210 −0.032 −0.103 −0.166 −0.181 −0.072 0.037
, latency (Lat.), number of bouts (NB), total time of grooming (TTG), average duration of
ber of incorrect bouts (NIB), number of complete bout (NCB), % of the NCB, number of
% of CT. Elevated plus maze: open arms (OA), closed arms (CA), closed arm return (CAR)
sing. a Pb0.05.
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mic and direct effects of progesterone in anxiety-like behaviors
(Galeeva and Tuohimaa, 2001). Taken together, these observations
suggest that benzodiazepine anxiolytic effect depends on the estrous
phase, with a higher response of diazepam anxiolytic effect during
estrus and diestrus phases (Bitran and Dowd, 1996). Furthermore, we
also observed that clonazepam is capable of normalizing pre-existing
estrous phase behavioral differences observed in control animals.
Grooming behavior is considered an index of behavioral habituation
to a stressful situation (Kametani, 1988). However, novelty-induced
grooming behavior can be observed early after moving the animal from
its cage to a new environment, or when the animal is exposed to other
stressors (Bindra and Spinner, 1958; Colbert et al., 1978). Pharmaco-
logical manipulation shows that anxiolytic drugs such as diazepam and
meprobamate decrease grooming-induced by stress-related peptides
(Crawley and Moody, 1983). A single dose of diazepam is also able
to decrease grooming behavior in rats (Aragão et al., 2006). The
neurosteroid allopregnanolone, a potent GABAA agonist and a proges-
terone metabolite, decreases the grooming frequency exhibited by rats
in response to a stressful experience (Zimmerberg et al., 1999).
Accordingly, anxiogenic drugs that inhibit central GABAergic system
production increase grooming activity (Adams et al., 1993; Barros et al.,
1994). By contrast, picrotoxin and bicuculline, GABAA antagonists,
reversed the decrease in grooming behavior produced by some GABA
agonists such as clonazepam, sodium valproate, and THIP (Barros et al.,
1994). These results indicate that grooming is related toGABAA function
and may indicate an anxiogenic-like behavior.
In this report, we analyzed the grooming behaviors in control and
clonazepam-treated rats by classical and microstructure analyses. We
also considered different estrous phases when comparing the results
from the elevated plus maze. As described before, males present less
frequency and duration of induced grooming than females, depending of
the estrous phase (Hill, et al., 2007). Several studies suggest that
contradictory data are observed when using grooming behavior as a
predictor of anxiolytic/anxiogenic events; bicuculline, a GABAA antago-
nist, decreased grooming (Périer et al., 2002), while muscimol, a GABAA
agonist, increased it (Osborne et al., 1993). Opposite responses observed
in classical analysis in different situations suggest that grooming should
be invalidated as a tool to evaluate emotions in animals (Henderson,
1970). Hence, a different method of observing grooming behavior in
rodents was proposed (Kalueff and Tuohimaa, 2004, 2005a, 2005b). The
microstructure analysis of grooming contributes to observations of
stress-like behavior when added to the classical analysis (Kalueff and
Tuohimaa, 2005b). In our study, the classical analysis showed an
anxiolytic effect of clonazepam; we found a decrease in the total time
of grooming, number of bouts and latency to grooming. These results are
consistent with those from previous studies using clonazepam (Barros
et al., 1994) and other anxiolytic GABAergic drugs (Barros et al., 1994; de
Souza Spinosa et al., 2000). In the microstructure analysis, the decrease
in the number of transitions and the increase in the percentage of correct
transitions helped us understand the pattern of this behavior after
clonazepam treatment. Clonazepam-treated animals not only developed
fewer grooming behaviors but also followed a sequence in a more
speciﬁc way, as we can see in the percentage of correct transitions. We
did not observe any alteration in the number of complete bouts using the
sequence from 0 to 0, which is the complete bout proposed by Kalueff
and Tuohimaa (2005a). Nor did we observe any alteration using an
alternative sequence from 1 to 5, which may bemore sensitive, or in the
percentage of incomplete bouts. However, the average duration of a bout
appeared to be a useful parameter in observing grooming alterations due
to drug treatment. Our results point to an association between behaviors
EPMT and grooming test and speciﬁc estrous phase, therefore, we may
infer that progesterone and/or estradiol play a role in regulating anxiety-
like behaviors.
Grooming tests and elevated plusmaze tests are not often combined
to determine anxiolytic drug effects. In the elevated plus maze test,there is evidence that the difference in estrous phase results in a
different duration in the open arm but does not change the grooming
duration, measured during only 5 min (Galeeva and Tuohimaa, 2001).
Here, we demonstrated that the two models when performed sepa-
rately are moderately associated, with a longer grooming analysis time
period (15 min). Some interesting correlationswere observed, especially
the total time of grooming, number of bouts (classical parameters),
number of actions and transitions (microstructure analysis) with the
closed arm return parameter. Rats that spent more time in the open arm
spent less time grooming, as expected from animals treated with an
anxiolytic drug. Though the grooming test was performed immediately
after the elevated plus maze test, our results may be considered isolated
data, because it is known that even after exposure to the elevated
plus maze test, it is still possible to observe alterations in grooming
microstructure activity in stress-induced mice (Kalueff and Tuohimaa,
2004).
5. Conclusions
In summary, we have shown that clonazepam exerts an anxiolytic
effect on female rats. This anxiolytic effect of clonazepam was
observed in the elevated plus maze test and also in the grooming
test. As expected, clonazepam decreased many grooming behaviors
both in the classical and the microstructure analyses. Our results
support the hypothesis that endogenous gonadal hormones play a
role on anxiety behavior. Clonazepam also had the potential to
decrease anxiety-like behaviors even during more anxiety-sensitive
estrous phases. Additionally, we suggest, through both classical and
microstructure analyses of grooming, that control female rats in the
proestrus phase display different behaviors compared to control rats
in other phases. Clonazepam treatment decreased the total transi-
tions and increased the rate of correct transitions of grooming,
thereby conﬁrming that its anxiolytic effect is observed not only by
reducing grooming frequency but also by improving its pattern.
Finally, the grooming microstructure test was moderately associated
with anxiety-like behaviors observed in the elevated plus maze test.
This observationmay be an important tool for detecting the anxiolytic
effect of drugs.
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